Deinove on Track to Receive Key Biomaterials Patent

Deinove (Paris), a biotech start-up, says the European Patent Office (EPO) has sent the company an “intention to grant" notice for a “foundational” biomaterials patent relating to the exploitation of deinococcus bacteria.   The patent covers a genetic engineering process invented by Deinove, which exploits deinococci's unique self-repair ability - a property which has enabled these bacteria to enrich their genome through natural evolution over 3 billion years, the company says. The self-repair characteristic has enabled the bacteria to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers